EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL). (February 2017) - Ascierto, P.; Bastholt, L.; Mohr, P.; Hoeller, C.; Robert, C.; Larkin, J.; Dummer, R.; Ekbom, A.; Chiarion-Sileni, V.; Dutriaux, C.; Mortier, L.; Neyns, B.; et al.